Home › Funds › Nantahala Capital Management, LLC › KRYS
Nantahala Capital Management, LLC position in KRYS
KRYSTAL BIOTECH INC · Health Care
Nantahala Capital Management, LLC reported holding 85,000 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$28.3M, representing 1.30% of its reported portfolio and ranking #22 among its reported holdings. Nantahala Capital Management, LLC has disclosed KRYS holdings in 7 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nantahala Capital Management, LLC's KRYS position evolved
Nantahala Capital Management, LLC first disclosed a stake in KRYS in Q2 2024 at 3,900 shares (US$716K). The position peaked in Q3 2025 at 200,000 shares, worth US$35.3M. Across 7 filings, Nantahala Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 85,000 shares valued at US$28.3M. Notable position changes include a 1282% increase in Q3 2024 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 3.90K | $716.20K | New |
| Q3 2024 | 53.90K | $9.81M | Add |
| Q4 2024 | 50.00K | $7.83M | Reduce |
| Q2 2025 | 200.00K | $27.49M | New |
| Q3 2025 | 200.00K | $35.31M | Hold |
| Q2 2026 | 85.00K | $31.59M | New |
| Q3 2026 | 85.00K | $28.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KRYS and 13F data
KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 42 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRYS
- Avoro Capital Advisors LLC 2.89M sh · $1.07B · Q2 2026
- Soleus Capital Management, L.P. 939.25K sh · $349.09M · Q2 2026
- Hood River Capital Management LLC 663.38K sh · $246.56M · Q2 2026
- Redmile Group, LLC 632.00K sh · $234.90M · Q2 2026
- Frazier Life Sciences Management, L.P. 481.31K sh · $178.89M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 520.92K sh · $173.24M · Q3 2026
- BRAIDWELL LP 128.97K sh · $47.94M · Q2 2026
More on Nantahala Capital Management, LLC
FAQ
How long has Nantahala Capital Management, LLC held KRYS?
Nantahala Capital Management, LLC has disclosed KRYS holdings in 7 of the last 10 reported quarters, going back to Q2 2024.
What is Nantahala Capital Management, LLC's current position in KRYS?
As of Q3 2026, Nantahala Capital Management, LLC holds 85.00K shares of KRYS (KRYSTAL BIOTECH INC), valued at $28.27M, representing 1.30% of its reported portfolio and ranking #22.
Has Nantahala Capital Management, LLC been buying or selling KRYS?
In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC held unchanged its position in KRYS. The position peaked in Q3 2025 at 200.00K shares.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.